3 Reasons Growth Investors Will Love CareTrust REIT (CTRE)

Zacks Investment Research highlights CareTrust REIT (CTRE) as a promising growth stock, citing a Growth Score of B and a Zacks Rank #2 (Buy). The recommendation is based on strong projected EPS growth of 20.5% this year, significantly outpacing the industry average, and a year-over-year cash flow growth of 67.6%. Furthermore, current-year earnings estimates for CareTrust REIT have seen upward revisions, reinforcing the positive outlook.

Analysis

CareTrust REIT (CTRE) has been identified as a compelling growth opportunity by Zacks Investment Research, supported by a Growth Score of B and a Zacks Rank #2 (Buy), a combination historically associated with market outperformance for growth stocks. This outlook is primarily driven by substantial projected earnings per share (EPS) growth of 20.5% for the current year, a figure that significantly eclipses the healthcare REIT industry average projection of 0.7%. Complementing this earnings trajectory, CTRE exhibits robust financial health with a year-over-year cash flow growth of 67.6%, starkly contrasting with the industry's 2.8% average. While its historical EPS growth was 1.1%, the forward-looking indicators are strong, further reinforced by a consistent annualized cash flow growth rate of 12.5% over the past 3-5 years, well above the industry's 3.1%. Critically, positive sentiment is also reflected in upward revisions to current-year earnings estimates, with the Zacks Consensus Estimate increasing by 0.6% over the last month, a factor often correlated with near-term stock performance.

Key Decisions for Investors

• Investors seeking growth within the healthcare REIT sector should consider CareTrust REIT due to its strong projected earnings and cash flow growth, coupled with positive analyst ratings and quantitative screening metrics.
• It is advisable to monitor upcoming earnings reports to verify the materialization of the projected 20.5% EPS growth and the sustainability of its high cash flow generation.
• Continued upward revisions in earnings estimates should be watched closely, as these are highlighted as strong indicators for potential near-term stock price appreciation for growth-focused equities like CTRE.